FRNRX | PGNAX | FRNRX / PGNAX | |
Total Expense Ratio | 1.01 | 1.26 | 80% |
Annual Report Gross Expense Ratio | 1.02 | 1.26 | 81% |
Fund Existence | 30 years | 35 years | - |
Gain YTD | 10.262 | 12.761 | 80% |
Front Load | 6% | 6% | 100% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328M | 697M | 47% |
Annual Yield % from dividends | 2.23 | 0.87 | 255% |
Returns for 1 year | 4.02 | 1.03 | 392% |
Returns for 3 years | 31.57 | 25.83 | 122% |
Returns for 5 years | 132.80 | 144.32 | 92% |
Returns for 10 years | 24.38 | 70.30 | 35% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
OARK | 8.93 | 0.08 | +0.90% |
YieldMax ARKK Option Income Strategy ETF | |||
PEY | 21.28 | 0.06 | +0.28% |
Invesco High Yield Eq Div Achiev™ ETF | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
LIAV | 233.21 | N/A | N/A |
LifeX 2061 Infl-Prt Longevity Inc ETF | |||
OBIL | 50.01 | -0.01 | -0.02% |
F/m US Treasury 12 Month Bill ETF |